276 related articles for article (PubMed ID: 31394288)
1. Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis.
Naganuma M; Kobayashi T; Nasuno M; Motoya S; Kato S; Matsuoka K; Hokari R; Watanabe C; Sakamoto H; Yamamoto H; Sasaki M; Watanabe K; Iijima H; Endo Y; Ichikawa H; Ozeki K; Tanida S; Ueno N; Fujiya M; Sako M; Takeuchi K; Sugimoto S; Abe T; Hibi T; Suzuki Y; Kanai T
Clin Gastroenterol Hepatol; 2020 May; 18(5):1102-1111.e5. PubMed ID: 31394288
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
[No Abstract] [Full Text] [Related]
3. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
Shimizu H; Ebana R; Kudo T; Sato T; Hara T; Hosoi K; Usami M; Yoshida M; Takeuchi I; Nakase H; Iwama I; Arai K; Shimizu T
J Gastroenterol; 2022 May; 57(5):344-356. PubMed ID: 35165800
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
Ma C; Lumb R; Walker EV; Foshaug RR; Dang TT; Verma S; Huang VW; Kroeker KI; Wong K; Dieleman LA; Fedorak RN; Halloran BP
Inflamm Bowel Dis; 2017 Sep; 23(9):1643-1649. PubMed ID: 28644184
[TBL] [Abstract][Full Text] [Related]
6. Assessment of disease activity by fecal immunochemical test in ulcerative colitis.
Ryu DG; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS
World J Gastroenterol; 2016 Dec; 22(48):10617-10624. PubMed ID: 28082814
[TBL] [Abstract][Full Text] [Related]
7. Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker.
Ishida N; Miyazu T; Matsuura T; Takano R; Tamura S; Kagami T; Tani S; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Furuta T; Sugimoto K
Int J Colorectal Dis; 2020 Sep; 35(9):1729-1739. PubMed ID: 32472230
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
[TBL] [Abstract][Full Text] [Related]
9. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
10. Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis.
Sakuraba A; Nemoto N; Hibi N; Ozaki R; Tokunaga S; Kikuchi O; Minowa S; Mitsui T; Miura M; Saito D; Hayashida M; Miyoshi J; Matsuura M; Yoneyama M; Ohnishi H; Hisamatsu T
BMC Gastroenterol; 2021 May; 21(1):197. PubMed ID: 33933033
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission.
Ishida N; Ito T; Takahashi K; Asai Y; Miyazu T; Higuchi T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Sugimoto K
World J Gastroenterol; 2023 Dec; 29(47):6111-6121. PubMed ID: 38186681
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.
Sandborn WJ; Panés J; Zhang H; Yu D; Niezychowski W; Su C
Gastroenterology; 2016 Jan; 150(1):96-102. PubMed ID: 26376350
[TBL] [Abstract][Full Text] [Related]
14. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
15. Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity.
Nakov RV; Nakov VN; Gerova VA; Tankova LT
Folia Med (Plovdiv); 2019 Jun; 61(2):188-196. PubMed ID: 31301663
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis.
Ryu DG; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS
Medicine (Baltimore); 2019 Sep; 98(36):e17080. PubMed ID: 31490411
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.
Dulai PS; Feagan BG; Sands BE; Chen J; Lasch K; Lirio RA
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):456-466.e7. PubMed ID: 35934286
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.
Ishida N; Higuchi T; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
Sci Rep; 2021 Jun; 11(1):12431. PubMed ID: 34127687
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
